{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:33:01Z","timestamp":1790371981674,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuropharm.2025.110778","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:35:04Z","timestamp":1763771704000},"page":"110778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cyclooxygenase 2 (COX-2) expression is elevated in prefrontal cortex neurons, not microglia, following methamphetamine self-administration in male and female rats"],"prefix":"10.1016","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5713-9026","authenticated-orcid":false,"given":"Amanda M.","family":"Acu\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3487-2009","authenticated-orcid":false,"given":"Rebecca","family":"Whittington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5162-2616","authenticated-orcid":false,"given":"Emma","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1036-7191","authenticated-orcid":false,"given":"Serena E.","family":"Rodarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Legg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4980-6926","authenticated-orcid":false,"given":"Hiba","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie W.","family":"Karugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-0351","authenticated-orcid":false,"given":"M. Foster","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110778_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578530","article-title":"Characterization of serum and brain cytokine levels following prolonged binge-like methamphetamine self-administration and cued methamphetamine seeking","volume":"400","author":"Acu\u00f1a","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/14656566.2024.2360653","article-title":"Promising immunomodulators for management of substance and alcohol use disorders","volume":"25","author":"Acu\u00f1a","year":"2024","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110778_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2025.100207","article-title":"Methamphetamine produces behavioral flexibility deficits that are attenuated by COX-2 inhibition in both male and female rats","volume":"15","author":"Acu\u00f1a","year":"2025","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110778_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prostaglandins.2009.04.003","article-title":"Emerging roles of PGE2 receptors in models of neurological disease","volume":"91","author":"Andreasson","year":"2010","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.neuropharm.2025.110778_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2003.08.015","article-title":"Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug","volume":"352","author":"Asanuma","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110778_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00509","article-title":"Chronic voluntary oral methamphetamine induces deficits in spatial learning and hippocampal protein kinase Mzeta with enhanced astrogliosis and cyclooxygenase-2 levels","volume":"4","author":"Avila","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2025.110778_bib7","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1523\/JNEUROSCI.20-11-04320.2000","article-title":"Medial frontal cortex mediates perceptual attentional set shifting in the rat","volume":"20","author":"Birrell","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2013.04.037","article-title":"Neural structures underlying set-shifting: roles of medial prefrontal cortex and anterior cingulate cortex","volume":"250","author":"Bissonette","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110778_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fneur.2017.00251","article-title":"Highly selective Cyclooxygenase-1 inhibitors P6 and Mofezolac counteract inflammatory state both in vitro and in vivo models of neuroinflammation","volume":"8","author":"Calvello","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib10","first-page":"1","article-title":"Cognitive impairment and changes of red blood cell components and serum levels of IL-6, IL-18, and L-tryptophan in methamphetamine abusers","volume":"12","author":"Chaidee","year":"2023","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/j.neuropharm.2025.110778_bib11","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1152\/jn.2002.87.6.2851","article-title":"Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity","volume":"87","author":"Chen","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40360-020-00406-5","article-title":"Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS\/MS and its application to pharmacokinetics studies","volume":"21","author":"Chen","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.neuropharm.2025.110778_bib13","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2019.2988","article-title":"Antigen retrieval pre-treatment causes a different expression pattern of Cav3.2 in rat and mouse spinal dorsal horn","volume":"63","author":"Cheng","year":"2019","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.neuropharm.2025.110778_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4168\/aair.2014.6.5.449","article-title":"Prostaglandin E2 induces IL-6 and IL-8 production by the EP Receptors\/Akt\/NF-kappaB pathways in nasal polyp-derived fibroblasts","volume":"6","author":"Cho","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.neuropharm.2025.110778_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tips.2009.01.002","article-title":"The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research","volume":"30","author":"Choi","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bpsgos.2021.07.011","article-title":"A cAMP-related gene network in microglia is inversely regulated by morphine tolerance and withdrawal","volume":"2","author":"Coffey","year":"2022","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"10.1016\/j.neuropharm.2025.110778_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pbb.2013.08.005","article-title":"96-hour methamphetamine self-administration in male and female rats: a novel model of human methamphetamine addiction","volume":"111","author":"Cornett","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110778_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109537","article-title":"The effect of the NLRP1 inflammasome on methamphetamine-induced cognitive impairment in rats","volume":"237","author":"Fan","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110778_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbi.2015.08.001","article-title":"The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine","volume":"51","author":"Frank","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2025.110778_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1460-9568.2009.07059.x","article-title":"Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin","volume":"31","author":"Goncalves","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib21","doi-asserted-by":"crossref","first-page":"27279","DOI":"10.1074\/jbc.M116.737353","article-title":"Spontaneous glutamatergic synaptic activity regulates constitutive COX-2 expression in neurons: opposing roles for the transcription factors CRED (cAMP response element binding) protein and Sp1 (stimulatory protein 1)","volume":"291","author":"Hewett","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110778_bib22","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1038\/s41598-017-09528-z","article-title":"Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype","volume":"7","author":"Kang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110778_bib23","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1073\/pnas.93.6.2317","article-title":"COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex","volume":"93","author":"Kaufmann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110778_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9120340","article-title":"Evaluation of microglia\/macrophage cells from rat striatum and prefrontal cortex reveals differential expression of inflammatory-related mRNA after methamphetamine","volume":"9","author":"Kays","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2019.01.007","article-title":"Neuroinflammation in addiction: a review of neuroimaging studies and potential immunotherapies","volume":"179","author":"Kohno","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110778_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2018.04.037","article-title":"The relationship between interleukin-6 and functional connectivity in methamphetamine users","volume":"677","author":"Kohno","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110778_bib27","first-page":"E246","article-title":"Effect of intravenous injection of IL-1 beta on PGE2 levels in several brain areas as determined by microdialysis","volume":"262","author":"Komaki","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/mol.58.6.1247","article-title":"Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6","volume":"58","author":"Ladenheim","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib29","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1523\/JNEUROSCI.0853-14.2014","article-title":"Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway","volume":"34","author":"Lee","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib30","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/s41380-024-02443-6","article-title":"Microglia in neuroimmunopharmacology and drug addiction","volume":"29","author":"Li","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110778_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbi.2019.03.016","article-title":"Methamphetamine-associated cognitive decline is attenuated by neutralizing IL-1 signaling","volume":"80","author":"Li\u015bkiewicz","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2025.110778_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12640-010-9223-x","article-title":"Methamphetamine causes persistent immune dysregulation: a cross-species, translational report","volume":"20","author":"Loftis","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2025.110778_bib33","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1007\/s12035-020-02087-x","article-title":"The role of brain cyclooxygenase-2 (Cox-2) beyond neuroinflammation: neuronal homeostasis in memory and anxiety","volume":"57","author":"L\u00f3pez","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib34","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1038\/s41467-024-53521-w","article-title":"Reward recalibrates rule representations in human amygdala and hippocampus intracranial recordings","volume":"15","author":"Manssuer","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110778_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbr.2003.09.019","article-title":"Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat","volume":"146","author":"McAlonan","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110778_bib36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s40478-023-01672-0","article-title":"Spatio-temporal dynamics of microglia phenotype in human and murine cSVD: impact of acute and chronic hypertensive states","volume":"11","author":"Morton","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neuropharm.2025.110778_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.jcbfm.9600106","article-title":"NFkappaB activates in vivo the synthesis of inducible Cox-2 in the brain","volume":"25","author":"Nadjar","year":"2005","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2023.1275968","article-title":"Effects of repeated binge intake of the pyrovalerone cathinone derivative 3,4-methylenedioxypyrovalerone on prefrontal cytokine levels in rats - a preliminary study","volume":"17","author":"Nagy","year":"2023","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14050435","article-title":"Methamphetamine and the synthetic cathinone 3,4-Methylenedioxypyrovalerone (MDPV) produce persistent effects on prefrontal and striatal microglial morphology and neuroimmune signaling following repeated binge-like intake in Male and female rats","volume":"14","author":"Nagy","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40035-023-00366-w","article-title":"Update on the pathological roles of prostaglandin E(2) in neurodegeneration in amyotrophic lateral sclerosis","volume":"12","author":"Nango","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110778_bib42","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1523\/JNEUROSCI.2745-07.2007","article-title":"Double dissociation of attentional resources: prefrontal versus cingulate cortices","volume":"27","author":"Ng","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib43","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1111\/ejn.16165","article-title":"The crucial role that hippocampus Cyclooxygenase-2 plays in memory","volume":"58","author":"Ni","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2018.12.003","article-title":"Methamphetamine and its immune-modulating effects","volume":"121","author":"Papageorgiou","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.neuropharm.2025.110778_bib45","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1073858406290794","article-title":"Lipid signaling and synaptic plasticity","volume":"12","author":"Sang","year":"2006","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2025.110778_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1196\/annals.1401.001","article-title":"Reconciling the roles of orbitofrontal cortex in reversal learning and the encoding of outcome expectancies","volume":"1121","author":"Schoenbaum","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00702-025-02932-0","article-title":"Therapeutic potential of COX-2 inhibitors in neuropsychiatric disorders","volume":"132","author":"Sharma","year":"2025","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2025.110778_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhae319","article-title":"GABA system in the prefrontal cortex involved in psychostimulant addiction","volume":"34","author":"Shi","year":"2024","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2025.110778_bib50","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1021\/acs.jmedchem.1c00816","article-title":"EP2 antagonists (2011-2021): a decade's journey from discovery to therapeutics","volume":"64","author":"Sluter","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110778_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114729","article-title":"Deciphering the mechanisms of regulation of an excitatory synapse via cyclooxygenase-2. A review","volume":"192","author":"Stachowicz","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib52","doi-asserted-by":"crossref","first-page":"13710","DOI":"10.1523\/JNEUROSCI.3544-11.2011","article-title":"Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection","volume":"31","author":"Stark","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib53","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/jpet.104.080242","article-title":"Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity","volume":"313","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110778_bib54","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1523\/JNEUROSCI.1142-09.2009","article-title":"Anterior cingulate neurons represent errors and preparatory attention within the same behavioral sequence","volume":"29","author":"Totah","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110778_bib55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1152\/physiolgenomics.00006.2019","article-title":"Medial prefrontal cortex in neurological diseases","volume":"51","author":"Xu","year":"2019","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.neuropharm.2025.110778_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110778_bib57","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2174\/138161208784480144","article-title":"Cyclooxygenase-2 in synaptic signaling","volume":"14","author":"Yang","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2025.110778_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1471-4159.2008.05766.x","article-title":"Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor","volume":"108","author":"Yang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110778_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.594766","article-title":"The relationship between serum cytokine levels and the degree of psychosis and cognitive impairment in patients with methamphetamine-associated psychosis in Chinese patients","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110778_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.14530","article-title":"Prostaglandin-cytokine crosstalk in chronic inflammation","volume":"176","author":"Yao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110778_bib61","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0266-18.2018","article-title":"3DMorph automatic analysis of microglial morphology in three dimensions from Ex vivo and in vivo imaging","volume":"5","author":"York","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2025.110778_bib62","first-page":"966","article-title":"COX-2 contributes to LPS-induced Stat3 activation and IL-6 production in microglial cells","volume":"10","author":"Zhu","year":"2018","journal-title":"Am J Transl Res"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:19:02Z","timestamp":1781191142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825004861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"alternative-id":["S0028390825004861"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110778","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclooxygenase 2 (COX-2) expression is elevated in prefrontal cortex neurons, not microglia, following methamphetamine self-administration in male and female rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110778"}}